BioSpace News Archive

Business

23andMe and TrialSpark Announce Joint Clinical Trial Offering and Request For Proposals

23andMe and TrialSpark are announcing a joint clinical trial offering that combines the power of 23andMe’s crowdsourced research platform and extensive database of consenting customers with TrialSpark’s distributed site network and trial services.

September 26, 2019
·
6 min read
Deals

Centene and WellCare Announce Agreement Between WellCare and Anthem, Inc., to Divest Missouri and Nebraska Medicaid Plans

Centene Corporation and WellCare Health Plans, Inc. announced that, in connection with the previously announced merger agreement between Centene and WellCare, a subsidiary of WellCare has entered into a definitive agreement under which Anthem, Inc. will acquire WellCare’s Missouri and Nebraska Medicaid plans.

September 26, 2019
·
21 min read
GE Expands SF6-free High-Voltage Product Portfolio to Help Cut Global Greenhouse Gas Emissions

GE Renewable Energy’s Grid Solutions business announced plans to invest tens of millions of dollars to expand its range of sulfur hexafluoride-free high-voltage substation equipment to include all key high-voltage levels by 2025.

September 26, 2019
·
5 min read
Business

The Hereditary Neuropathy Foundation Shares Voice of the Patient (VoP) Report

VoP Report was recently published on the FDA website, highlights the results of the Externally-led Patient-Focused Drug Development (PFDD) Meeting [26-September-2019] NEW YORK , Sept. 26, 2019 /PRNewswire/ -- The Hereditary Neuropathy Foundation (HNF) is proud to share the Voice of the Patient (VoP) Report which was recently published on the FDA website. The report hi

September 26, 2019
·
4 min read
Business

BD Announces Leadership Succession Plan

BD (Becton, Dickinson and Company) announced that Vincent A. Forlenza, chairman and CEO, will retire as CEO on Jan. 28, 2020, following the company’s annual meeting of shareholders.

September 26, 2019
·
8 min read
Policy

Synthetic Biologics Strengthens U.S. Patent Coverage of SYN-010, Intended for the Novel Treatment of Irritable Bowel Syndrome with Constipation (IBS-C)

Issuance of New Patent and Allowance of Patent Application Diversifies SYN-010 Protection in US

September 26, 2019
·
6 min read
Business

CollPlant Reports Second Quarter 2019 Financial Results and Provides Business Update

CollPlant, a regenerative medicine company, announced financial results for the second quarter ended June 30, 2019 and provided an update on the Company’s business developments.

September 26, 2019
·
11 min read
Biotech Bay

New Clinical Results from RheOx™ System for Chronic Bronchitis to be Presented at European Respiratory Society (ERS) International Congress

Gala Therapeutics, Inc. announced that clinical results and a patient case involving its RheOxTM Bronchial Rheoplasty system will be presented at the 2019 ERS International Congress, occurring Sept. 28 - Oct. 2, 2019 in Madrid, Spain.

September 26, 2019
·
3 min read
Deals

Tetraphase Pharmaceuticals Announces Reverse Stock Split

Tetraphase Pharmaceuticals, Inc. announced that it will effect a 1-for-20 reverse stock split of its common stock that will be effective at 5:00 p.m. Eastern Time.

September 26, 2019
·
4 min read
Business

David H. Witte to lead MBP Titan LLC

Former head of IHS Markit Energy, Chemicals and Agribusiness Division to lead company for Intrexon’s Methane Bioconversion Platform (MBP)

September 26, 2019
·
4 min read